HIPAA

April 15, 2020 WPF Statement on the COVID-19 Community Based Testing Sites HIPAA Waiver

In response to the COVID-19 (coronavirus) pandemic, the U.S. Department of Health and Human Services announced a HIPAA waiver April 9, 2020 regarding Community Based Testing Sites, which waives enforcement of all HIPAA privacy and security protections and data breach rules from some health care activities affecting COVID-19 testing.  This statement from WPF includes the following information:  
-What are the changes the Community Based Testing Sites HIPAA waiver creates? 
-What are the privacy concerns? 
-WPF recommendations to correct the privacy problems in the Community Based Testing Sites HIPAA waiver  
-Background on HIPAA waivers and a list of all current waivers in force

April 6, 2020 WPF Statement on COVID-19 Business Associate HIPAA Waiver

In response to the COVID-19 (coronavirus) pandemic, the U.S. Department of Health and Human Services announced a HIPAA waiver April 2, 2020 regarding Business Associates. The April 2 waiver is consequential and poses significant privacy challenges. This statement from WPF includes the following information:  
-What are the changes to HIPAA the April 2 waiver creates? 
-What are the privacy concerns? 
-WPF recommendations to correct the problems in the April 2, 2020 waiver  

March 18 WPF Statement on COVID-19 Telehealth HIPAA Waiver

In response to the COVID-19 (coronavirus) pandemic, the U.S. Department of Health and Human Services announced some changes in HIPAA practices. This statement from WPF includes the following information:  
-What are the changes to HIPAA during the COVID-19 emergency? 
-What are the privacy concerns? 
-WPF recommendations to ensure patient privacy is protected  

WPF urges National Institutes of Health to expand privacy guidance for researchers

WPF is urging the National Institutes of Health to do more to properly advise the research community and to protect data subjects in its draft guidance on data management and sharing. WPF is asking for changes to the NIH guidance because in the US, much health research data in the hands of researchers is not subject to the privacy or security rules in HIPAA.